Gilead is set to launch a Phase III trial of its once-yearly lenacapavir pre-exposure prophylaxis (PrEP) for human immunodeficiency virus (HIV) following the success of a Phase I study. The Phase ...

UNAIDS : The AIDS-fighting agency said Wednesday that U.S. funding has “served as the backbone” for HIV prevention in many countries hit hard by the virus. U.S. funding amounts to 55% of the ...

Entitled Together we will end AIDS, the new UNAIDS report contains the latest data on numbers of new HIV infections, numbers of people receiving antiretroviral treatment, AIDS-related deaths and HIV ...

In 2012, there were 35.3 million [32.2 million–38.8 million] people living with HIV. Since the start of the epidemic around 75 million [63 million–89 million] have become infected with HIV. New HIV ...

UNAIDS : The AIDS-fighting agency said Wednesday that U.S. funding has “served as the backbone” for HIV prevention in many countries hit hard by the virus. U.S. funding amounts to 55% of the total ...

'Unacceptable': Fiji Rugby demands answers following Drua's mistreatment in NZ ...